HYBRID EVENT: You can participate in person at Tokyo, Japan from your home or work.
7th Edition of Cardiology World Conference
October 08-10, 2026 | Tokyo, Japan
Cardiovascular Pharmacology
Cardiovascular Pharmacology
Cardiovascular pharmacology: Cardiovascular pharmacology involves drugs that are used in the treatment of cardiovascular diseases. Many medications are used to treat various heart conditions. Some examples of the drugs used as cardiovascular medicine include:
- Anticoagulants or blood thinners
- Antiplatelet agents
- Thrombolytic agents
- Angiotensin-converting enzyme (ACE) inhibitors
- Angiotensin II receptor blockers (ARBs)
- Diuretics
- Calcium channel blockers
- Vasodilators
- Digoxin
Committee Members
Narendra Kumar
HeartbeatsZ Academy, United Kingdom
Yong Xiao Wang
Albany Medical Center, United States
Robert J Chilton
University of Texas Health Science Center San Antonio, United States Cardio 2026 Speakers
Sergey Suchkov
N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Narendra Kumar
HeartbeatsZ Academy, United Kingdom
Yong Xiao Wang
Albany Medical Center, United States
Robert J Chilton
University of Texas Health Science Center San Antonio, United StatesSubmit your abstract Today
Title : Investigating the long-term follow up of atrial septal device closures in wales and england: A comparative analysis with major adverse cardiovascular Events (MACE)
Meera Gopinath, Cardiff University Medical school, United Kingdom
Title : An adult case of polysplenia syndrome associated with sinus node dysfunction
Apoorva Tripathi, Oxford University Hospitals, United Kingdom
Title : A unique cell-driven phenomenon in the heart and the promising future of the innovative translational tools to manage cardiac self-renewal and regeneration
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Yasser’s criterion of inferior ST-segment discrepancy deviations in AF with aberrancy and Sgarbosa criteria - a new cardiovascular discovery and management - a case report
Yasser Mohammed Hassanain Elsayed, Egyptian Ministry of Health, Egypt